Arteriovenous malformation of cerebral vessels
ICD-10 Q28.2 is a billable code used to indicate a diagnosis of arteriovenous malformation of cerebral vessels.
Arteriovenous malformations (AVMs) of cerebral vessels are congenital vascular anomalies characterized by an abnormal connection between arteries and veins, bypassing the capillary system. This condition can lead to significant neurological complications, including hemorrhage, seizures, and neurological deficits. AVMs can occur in various locations within the brain and may present with symptoms such as headaches, focal neurological deficits, or even be asymptomatic until a rupture occurs. Diagnosis typically involves imaging studies such as MRI or CT angiography. Treatment options may include surgical resection, endovascular embolization, or stereotactic radiosurgery, depending on the size, location, and symptoms associated with the AVM. The management of AVMs requires a multidisciplinary approach, often involving neurosurgeons, interventional radiologists, and neurologists. Early detection and intervention are crucial to prevent complications and improve outcomes.
Pediatric documentation should include growth parameters, developmental milestones, and specific neurological assessments related to AVMs.
Common scenarios include a pediatric patient presenting with seizures or headaches, requiring imaging to evaluate for AVMs.
Considerations include the impact of AVMs on developmental progress and the need for long-term follow-up.
Genetic documentation may include family history of vascular anomalies and any syndromic associations.
Scenarios may involve genetic counseling for families with a history of AVMs or related syndromes.
Considerations include the potential for hereditary syndromes that may predispose to AVMs.
Used when treating an AVM through minimally invasive techniques.
Document the indication for the procedure, imaging findings, and post-procedure follow-up.
Neurosurgical documentation may require additional details on the approach and technique used.
Documenting associated symptoms is crucial for accurate coding and understanding the clinical impact of the AVM on the patient's health. It also supports the medical necessity of treatments provided.
